Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: an In-Silico Strategy to Prevent TDP-43 Aggregation
Biorxiv : the Preprint Server for Biology
|November 14, 2023
Summary
Researchers designed peptide therapeutics using computational methods to prevent the aggregation of TDP-43, a protein implicated in neurodegenerative diseases like ALS and FTD. Promising peptides were identified that stabilize the protein
Area of Science:
- Neuroscience and Molecular Biology
- Biochemistry and Biophysics
Background:
- TDP-43 protein aggregation is a key pathological hallmark of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
- The destabilization of an alpha-helical segment in TDP-43's C-terminal region facilitates the formation of pathological amyloid-like filaments, disrupting neuronal function.
- Targeting this destabilization offers a potential therapeutic strategy to halt disease progression.
Conclusions:
- Alpha-helical propensity peptides represent potential lead molecules for novel therapeutics targeting TDP-43 aggregation.
- This structure-based computational design approach offers a new avenue for developing interventions for ALS, FTD, and related neurodegenerative diseases.
- The identified peptides warrant further in vitro and in vivo validation.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K